Drug Development Technology: Frost & Sullivan Award goes to Imperacer
The 2008 European Immunoassay Frost & Sullivan Excellence in Technology Award has been awarded to Chimera Biotec. Chimera Biotec is recognized for its pioneering Imperacer® ultra-sensitive immunoassay system, which has a 1000-fold better sensitivity compared to ELISA (Enzyme-linked Immunosorbent Assay), according to the company. With a unique value proposition in the drug development and diagnostic markets, Chimera's innovative Imperacer® products and services have experience widespread market acceptance. “Imperacer® has a proven record for quantifying low-abundant proteins, peptides, biomarkers and a range of “difficult to quantify” markers”, says Mark Spengler, Product Manager at Chimera Biotec. “Among others Imperacer® is currently being used in fields like Alzheimer’s, rheumatoid arthritis, cardiovascular and cancer.”
Launched in 2005, Imperacer® has been successfully used in a number of applications like drug development (preclinic & clinic), vaccine development, diagnostics, anti-doping testing, and proteomics. Imperacer® usually is 3 orders of magnitude more sensitive than any ELISA and is, therefore, mainly used for quantifying low abundant markers that cannot be quantified using conventional ELISA or electrochemiluminescence- technologies (ECL). Imperacer® is characterized by a broad linearity of up to 5 orders of magnitude and can be adapted to sample volumes of less than a microliter. Complementary to Imperacer®, Chimera developed a range of proprietary technologies for eliminating sample interferences (AnySource® technology) and analyte stabilization.
“After having been successfully introduced Imperacer® in research labs in 7 out of TOP 20 pharmaceutical and biotech companies in the U.S. and Switzerland we are now actively exploring broader global markets to expand our services," states Jan Detmers, CEO of Chimera Biotec.
Most read news
Topics
Organizations
Other news from the department business & finance
These products might interest you

Kjel- / Dist Line by Büchi
Kjel- and Dist Line - steam distillation and Kjeldahl applications
Maximum accuracy and performance for your steam distillation and Kjeldahl applications

AZURA Purifier + LH 2.1 by KNAUER
Preparative Liquid Chromatography - New platform for more throughput
Save time and improve reproducibility during purification

Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.